rs10848683

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000682544.1(CACNA1C):​c.5693C>T​(p.Pro1898Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.796 in 1,596,264 control chromosomes in the GnomAD database, including 511,775 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P1898P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.71 ( 40081 hom., cov: 32)
Exomes 𝑓: 0.80 ( 471694 hom. )

Consequence

CACNA1C
ENST00000682544.1 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.47

Publications

38 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
ITFG2-AS1 (HGNC:53128): (ITFG2 antisense RNA 1)
CACNA1C-AS1 (HGNC:40119): (CACNA1C antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.8183505E-6).
BP6
Variant 12-2681964-C-T is Benign according to our data. Variant chr12-2681964-C-T is described in ClinVar as Benign. ClinVar VariationId is 136638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.82 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.5445-586C>T intron_variant Intron 42 of 46 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.5445-586C>T intron_variant Intron 42 of 46 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000682544.1 linkc.5693C>T p.Pro1898Leu missense_variant Exon 45 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000327702.12 linkc.5459C>T p.Pro1820Leu missense_variant Exon 43 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.5459C>T p.Pro1820Leu missense_variant Exon 43 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000399603.6 linkc.5445-586C>T intron_variant Intron 42 of 46 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.5445-586C>T intron_variant Intron 42 of 46 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000406454.8 linkc.5658-586C>T intron_variant Intron 43 of 47 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.5625-586C>T intron_variant Intron 42 of 46 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.5610-586C>T intron_variant Intron 43 of 47 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.5589-586C>T intron_variant Intron 44 of 48 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.5568-586C>T intron_variant Intron 42 of 46 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000682462.1 linkc.5535-586C>T intron_variant Intron 42 of 46 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.5535-586C>T intron_variant Intron 42 of 46 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.5535-586C>T intron_variant Intron 42 of 46 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.5535-586C>T intron_variant Intron 42 of 46 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.5529-586C>T intron_variant Intron 43 of 47 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.5520-586C>T intron_variant Intron 43 of 47 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.5505-586C>T intron_variant Intron 43 of 47 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.5502-586C>T intron_variant Intron 42 of 46 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.5502-586C>T intron_variant Intron 42 of 46 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.5502-586C>T intron_variant Intron 42 of 46 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.5496-586C>T intron_variant Intron 42 of 46 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.5487-586C>T intron_variant Intron 42 of 46 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.5469-586C>T intron_variant Intron 41 of 45 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.5469-586C>T intron_variant Intron 41 of 45 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.5463-586C>T intron_variant Intron 41 of 45 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.5445-586C>T intron_variant Intron 42 of 46 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.5445-586C>T intron_variant Intron 42 of 46 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.5445-586C>T intron_variant Intron 42 of 46 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.5445-586C>T intron_variant Intron 42 of 46 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.5445-586C>T intron_variant Intron 42 of 46 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.5436-586C>T intron_variant Intron 42 of 46 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.5412-586C>T intron_variant Intron 41 of 45 ENSP00000507309.1 Q13936-19

Frequencies

GnomAD3 genomes
AF:
0.713
AC:
107994
AN:
151514
Hom.:
40074
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.491
Gnomad AMI
AF:
0.631
Gnomad AMR
AF:
0.731
Gnomad ASJ
AF:
0.821
Gnomad EAS
AF:
0.594
Gnomad SAS
AF:
0.842
Gnomad FIN
AF:
0.854
Gnomad MID
AF:
0.731
Gnomad NFE
AF:
0.817
Gnomad OTH
AF:
0.711
GnomAD2 exomes
AF:
0.777
AC:
193185
AN:
248494
AF XY:
0.787
show subpopulations
Gnomad AFR exome
AF:
0.485
Gnomad AMR exome
AF:
0.769
Gnomad ASJ exome
AF:
0.815
Gnomad EAS exome
AF:
0.591
Gnomad FIN exome
AF:
0.852
Gnomad NFE exome
AF:
0.813
Gnomad OTH exome
AF:
0.789
GnomAD4 exome
AF:
0.804
AC:
1162010
AN:
1444634
Hom.:
471694
Cov.:
30
AF XY:
0.807
AC XY:
580629
AN XY:
719614
show subpopulations
African (AFR)
AF:
0.473
AC:
15699
AN:
33158
American (AMR)
AF:
0.764
AC:
34128
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.815
AC:
21199
AN:
26018
East Asian (EAS)
AF:
0.576
AC:
22831
AN:
39612
South Asian (SAS)
AF:
0.843
AC:
72356
AN:
85812
European-Finnish (FIN)
AF:
0.848
AC:
45124
AN:
53234
Middle Eastern (MID)
AF:
0.776
AC:
3572
AN:
4602
European-Non Finnish (NFE)
AF:
0.820
AC:
900383
AN:
1097810
Other (OTH)
AF:
0.782
AC:
46718
AN:
59710
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.418
Heterozygous variant carriers
0
9959
19918
29878
39837
49796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20454
40908
61362
81816
102270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.712
AC:
108036
AN:
151630
Hom.:
40081
Cov.:
32
AF XY:
0.716
AC XY:
53006
AN XY:
74058
show subpopulations
African (AFR)
AF:
0.491
AC:
20320
AN:
41368
American (AMR)
AF:
0.731
AC:
11142
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.821
AC:
2847
AN:
3468
East Asian (EAS)
AF:
0.593
AC:
3037
AN:
5120
South Asian (SAS)
AF:
0.842
AC:
4057
AN:
4820
European-Finnish (FIN)
AF:
0.854
AC:
8980
AN:
10512
Middle Eastern (MID)
AF:
0.731
AC:
212
AN:
290
European-Non Finnish (NFE)
AF:
0.817
AC:
55369
AN:
67800
Other (OTH)
AF:
0.712
AC:
1500
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1458
2916
4373
5831
7289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.786
Hom.:
157522
Bravo
AF:
0.692
TwinsUK
AF:
0.814
AC:
3018
ALSPAC
AF:
0.807
AC:
3112
ESP6500AA
AF:
0.504
AC:
1581
ESP6500EA
AF:
0.821
AC:
5884
ExAC
AF:
0.772
AC:
92945
Asia WGS
AF:
0.708
AC:
2459
AN:
3478
EpiCase
AF:
0.817
EpiControl
AF:
0.807

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Jul 14, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Timothy syndrome Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
0.16
DANN
Benign
0.54
DEOGEN2
Benign
0.014
T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.00024
N
MetaRNN
Benign
0.0000018
T;T
MetaSVM
Benign
-0.95
T
PhyloP100
-1.5
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.6
N;N
REVEL
Benign
0.19
Sift
Benign
0.24
T;T
Sift4G
Benign
0.10
T;T
Vest4
0.066
ClinPred
0.0050
T
GERP RS
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10848683; hg19: chr12-2791130; COSMIC: COSV59713321; COSMIC: COSV59713321; API